{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T12:04:16Z","timestamp":1793880256524,"version":"4.7.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-14-1-0585"],"award-info":[{"award-number":["W81XWH-14-1-0585"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["4UH3EY031809-02"],"award-info":[{"award-number":["4UH3EY031809-02"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["VR170180"],"award-info":[{"award-number":["VR170180"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jtos.2025.05.009","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T02:54:15Z","timestamp":1747968855000},"page":"8-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Safety of subconjunctival injection of mesenchymal stromal cells in persistent corneal epithelial disease \u2013 A phase 1b clinical trial"],"prefix":"10.1016","volume":"38","author":[{"given":"Grace C.","family":"Tu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farshad","family":"Abedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur Y.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Soleimani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iskra","family":"Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeonghyun","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khandeker N.","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohreh","family":"Arabpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadim","family":"Mahmud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmer Y.","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Dana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiman","family":"Hematti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte E.","family":"Joslin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali R.","family":"Djalilian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jtos.2025.05.009_bib1","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/term.2914","article-title":"Mesenchymal stem cells: cell therapy and regeneration potential","volume":"13","author":"Brown","year":"2019","journal-title":"J Tissue Eng Regen Med"},{"issue":"10","key":"10.1016\/j.jtos.2025.05.009_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1167\/tvst.10.10.3","article-title":"Preclinical evaluation of the safety and efficacy of cryopreserved bone marrow mesenchymal stromal cells for corneal repair","volume":"10","author":"Putra","year":"2021","journal-title":"Transl Vis Sci Technol"},{"issue":"5","key":"10.1016\/j.jtos.2025.05.009_bib3","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s12015-022-10369-1","article-title":"A brief overview of global trends in MSC-based cell therapy","volume":"18","author":"Jovic","year":"2022","journal-title":"Stem Cell Rev Rep"},{"key":"10.1016\/j.jtos.2025.05.009_bib4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jtos.2022.10.003","article-title":"Trends in using mesenchymal stromal\/stem cells (MSCs) in treating corneal diseases","volume":"26","author":"Venkatakrishnan","year":"2022","journal-title":"Ocul Surf"},{"issue":"6","key":"10.1016\/j.jtos.2025.05.009_bib5","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1080\/14712598.2023.2175605","article-title":"Applications of mesenchymal stem cells in ocular surface diseases: sources and routes of delivery","volume":"23","author":"Soleimani","year":"2023","journal-title":"Expet Opin Biol Ther"},{"issue":"5","key":"10.1016\/j.jtos.2025.05.009_bib6","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/stem.2781","article-title":"Cornea-derived mesenchymal stromal cells therapeutically modulate macrophage immunophenotype and angiogenic function","volume":"36","author":"Eslani","year":"2018","journal-title":"Stem Cell"},{"key":"10.1016\/j.jtos.2025.05.009_bib7","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jtos.2024.11.001","article-title":"Adipose-derived mesenchymal stromal cells: a study on safety and efficacy in ocular inflammation","volume":"34","author":"Rusch","year":"2024","journal-title":"Ocul Surf"},{"issue":"19","key":"10.1016\/j.jtos.2025.05.009_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911510","article-title":"Therapeutic potential of mesenchymal stem cell-secreted factors on delay in corneal wound healing by nitrogen mustard","volume":"23","author":"An","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.jtos.2025.05.009_bib9","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.3390\/pharmaceutics15051486","article-title":"Wound-healing effects of mesenchymal stromal cell secretome in the cornea and the role of exosomes","volume":"15","author":"An","year":"2023","journal-title":"Pharmaceutics"},{"issue":"11","key":"10.1016\/j.jtos.2025.05.009_bib10","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1097\/ICO.0000000000002442","article-title":"The effect of mesenchymal stem cell secretome on corneal endothelial cell preservation in an oxidative injury model","volume":"39","author":"Rabiee","year":"2020","journal-title":"Cornea"},{"issue":"12","key":"10.1016\/j.jtos.2025.05.009_bib11","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1167\/iovs.18-24803","article-title":"Effect of human corneal mesenchymal stromal cell-derived exosomes on corneal epithelial wound healing","volume":"59","author":"Samaeekia","year":"2018","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2025.05.009_bib12","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jtos.2024.10.005","article-title":"Target specification and therapeutic potential of extracellular vesicles for regulating corneal angiogenesis, lymphangiogenesis, and nerve repair","volume":"34","author":"Pedersen","year":"2024","journal-title":"Ocul Surf"},{"issue":"2","key":"10.1016\/j.jtos.2025.05.009_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030842","article-title":"Role of mesenchymal stem cells on cornea wound healing induced by acute alkali burn","volume":"7","author":"Yao","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jtos.2025.05.009_bib14","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jtos.2023.09.008","article-title":"Intrastromal versus subconjunctival injection of mesenchymal stem\/stromal cells for promoting corneal repair","volume":"30","author":"Soleimani","year":"2023","journal-title":"Ocul Surf"},{"issue":"23","key":"10.1016\/j.jtos.2025.05.009_bib15","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.3390\/cells12232744","article-title":"The potential of mesenchymal stem\/stromal cell therapy in mustard keratopathy: discovering new roads to combat cellular senescence","volume":"12","author":"Soleimani","year":"2023","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.jtos.2025.05.009_bib16","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.ophtha.2006.10.029","article-title":"New grading system for the evaluation of chronic ocular manifestations in patients with Stevens\u2013Johnson syndrome","volume":"114","author":"Sotozono","year":"2007","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.jtos.2025.05.009_bib17","first-page":"351","article-title":"Ocular graft versus host disease following allogeneic stem cell transplantation: a review of current knowledge and recommendations","volume":"8","author":"Nassiri","year":"2013","journal-title":"J Ophthalmic Vis Res"},{"key":"10.1016\/j.jtos.2025.05.009_bib18","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ajo.2020.05.035","article-title":"Prevalence of persistent corneal epithelial defects in chronic ocular graft-versus-host disease","volume":"218","author":"Sinha","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2025.05.009_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.836009","article-title":"A review of the diagnosis and treatment of limbal stem cell deficiency","volume":"9","author":"Kate","year":"2022","journal-title":"Front Med"},{"issue":"8","key":"10.1016\/j.jtos.2025.05.009_bib20","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s00296-020-04568-7","article-title":"Analysis of ocular surface damage and visual impact in patients with primary and secondary Sj\u00f6gren syndrome","volume":"40","author":"Villarreal-Gonzalez","year":"2020","journal-title":"Rheumatol Int"},{"issue":"3","key":"10.1016\/j.jtos.2025.05.009_bib21","first-page":"163","article-title":"Persistent corneal epithelial defects: a review article","volume":"8","author":"Vaidyanathan","year":"2019","journal-title":"Med Hypothesis, Discov Innovation (MEHDI) Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2025.05.009_bib22","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jtos.2014.12.005","article-title":"Novel therapy to treat corneal epithelial defects: a hypothesis with growth hormone","volume":"13","author":"Wirostko","year":"2015","journal-title":"Ocul Surf"},{"issue":"6","key":"10.1016\/j.jtos.2025.05.009_bib23","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1158\/1078-0432.CCR-09-1961","article-title":"Approaches to phase 1 clinical trial design focused on safety, efficiency, and selected patient populations: a report from the clinical trial design task force of the national cancer institute investigational drug steering committee","volume":"16","author":"Ivy","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtos.2025.05.009_bib24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jtos.2021.07.008","article-title":"Safety and feasibility of subconjunctival injection of mesenchymal stem cells for acute severe ocular burns: a single-arm study","volume":"22","author":"Liang","year":"2021","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2025.05.009_bib25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jtos.2020.11.013","article-title":"Safety and feasibility of mesenchymal stem cell therapy in patients with aqueous deficient dry eye disease","volume":"19","author":"M\u00f8ller-Hansen","year":"2021","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2025.05.009_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jtos.2023.11.007","article-title":"Allogeneic mesenchymal stem cell therapy for dry eye disease in patients with Sj\u00f6gren's syndrome: a randomized clinical trial","volume":"31","author":"M\u00f8ller-Hansen","year":"2024","journal-title":"Ocul Surf"}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012425000709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012425000709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T09:59:34Z","timestamp":1764755974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542012425000709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":26,"alternative-id":["S1542012425000709"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2025.05.009","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of subconjunctival injection of mesenchymal stromal cells in persistent corneal epithelial disease \u2013 A phase 1b clinical trial","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2025.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}